Navigation Links
PAREXEL International to Present at Oppenheimer 19th Annual Healthcare Conference
Date:10/31/2008

BOSTON, Oct. 31 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the Oppenheimer 19th Annual Healthcare Conference in New York, NY. James Winschel, Senior Vice President and Chief Financial Officer will be making a formal presentation on PAREXEL at 1:20 p.m. EST on Monday, November 3, 2008.

The presentation will be available under the "Upcoming Events" section on PAREXEL's "Investors" homepage at http://www.PAREXEL.com. After the conference, a PDF version of this presentation will be available under the "Webcasts and Presentations" section on our "Investors" homepage.

About the Company

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 52 countries around the world, and has over 9,180 employees. For more information about PAREXEL International visit http://www.parexel.com

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of their respective business and are hereby acknowledged.

CONTACT: Jill Baker, Vice President of Investor Relations

+1-781-434-4118


'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy
2. PAREXEL Corporate Vice President Dr. Alberto Grignolo Receives Lifetime Achievement Award From Good Clinical Practice Journal
3. PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average
4. PAREXEL International to Present at William Blair Small-Cap Growth Stock Conference
5. PAREXEL International Updates Financial Guidance in Conjunction With the Acquisition of ClinPhone Plc and Other Factors
6. PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference
7. PAREXEL Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
8. PAREXEL Closes the Acquisition of ClinPhone
9. PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results
10. PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer
11. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2008 Earnings Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2017)... ... 15, 2017 , ... Algenist is continuing to disrupt the ... cream with a patented formula, clinically proven to deliver visible firming results in ... Cream to our already innovative ELEVATE product line,” said vice president of product ...
(Date:5/12/2017)... ANN ARBOR, Mich. , May 12, 2017 /PRNewswire/ ... been selected to present at the 36th annual Michigan ... Investment Forum. GreenMark, a Delaware ... will be presenting to investors in attendance, including more ... to deliver health benefits to society through biobased targeting ...
(Date:5/11/2017)... SEATTLE, WA (PRWEB) , ... May 11, 2017 , ... ... regulatory review, is proud to announce that it has joined SMART IRB , ... The goal of SMART IRB is to ease burdens related to multi-site research and ...
(Date:5/10/2017)... ... May 10, 2017 , ... Shimadzu Scientific Instruments ... a host of technologically advanced features, resulting in a modernized instrument that improves ... yields a higher return on investment. , Engineered with the analyst in ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 No ... but researchers at the New York University Tandon ... of Engineering have found that partial similarities between ... systems used in mobile phones and other electronic ... The vulnerability lies in the fact ...
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:3/30/2017)... YORK , March 30, 2017 Trends, ... type (physiological and behavioral), by technology (fingerprint, AFIS, iris ... voice recognition, and others), by end use industry (government ... and immigration, financial and banking, and others), and by ... Europe , Asia Pacific , ...
Breaking Biology News(10 mins):